Diffusion of drugs in native and purified gastrointestinal mucus

Journal of Pharmaceutical Sciences
A W LarhedE Björk

Abstract

The mucus layer covering the surface of the gastrointestinal tract may act as a barrier to drug absorption. The aim of this investigation was to study the self-diffusion coefficients of model drugs with different physicochemical properties in gastrointestinal mucus. An in vitro method was used to determine the self-diffusion coefficients of radiolabeled model drugs in different diffusion media. Glucosamine, mannitol, glucuronic acid, glucose, metoprotol, antipyrine, propranolol, hydrocortisone, and testosterone, which display large differences in charge and octanol/water distribution ratios (K), were used as model drugs. The diffusion coefficients of model drugs were compared in phosphate buffer (PB), native pig intestinal mucus (PIM), and purified pig gastric much (PPGM). PIM was not purified and therefore contained all the original components of native mucus, whereas PPGM contained only high molecular weight mucin molecules. Charge had only minor effects on the diffusion coefficients of the model drugs. Lipophilicity, however, had a much larger effect, the largest decrease in diffusion coefficient, 58%, was observed for testosterone in PIM. A negative relationship between the diffusion coefficient and log K was observed in PI...Continue Reading

References

Dec 20, 1979·European Journal of Pharmacology·H LüllmannA Ziegler
Jul 1, 1992·The Journal of Pharmacy and Pharmacology·B T HenryT G Rogers
Jan 15, 1992·Experientia·M A DesaiP Vadgama
Jul 1, 1990·The Journal of Pharmacy and Pharmacology·D Winne, W Verheyen
Mar 1, 1986·Clinical Science·G W SmithC Tasman-Jones
Apr 1, 1983·The Biochemical Journal·I CarlstedtL Wingerup
Jan 1, 1982·Advances in Experimental Medicine and Biology·A AllenJ P Pearson
Jan 1, 1995·Annual Review of Physiology·L M Lichtenberger
Feb 1, 1994·Biophysical Journal·W M SaltzmanR A Cone

❮ Previous
Next ❯

Citations

Apr 2, 2004·Lipids·Timothy Scott WiedmannHeather Herrington
Mar 22, 2005·International Journal of Pharmaceutics·Kouki ObataYosinori Aso
May 28, 2013·International Journal of Pharmaceutics·Ellen HagesaetherTrond Ulven
Jun 4, 2013·International Journal of Pharmaceutics·Hakon H SigurdssonClaus-Michael Lehr
Dec 31, 2003·Journal of Colloid and Interface Science·Timothy Scott WiedmannHeather Herrington
May 23, 2001·Advanced Drug Delivery Reviews·K KhanvilkarD R Flanagan
Jun 6, 2000·Advanced Drug Delivery Reviews·D A NorrisP J Sinko
Jul 20, 2002·European Journal of Medicinal Chemistry·Michael H AbrahamIan Cooper
Apr 25, 2003·International Journal of Pharmaceutics·Kiyohiko SuganoYoshinori Aso
Jun 24, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C Meaney, C O'Driscoll
Jul 30, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·N G SchipperP Artursson
Oct 23, 2008·Lab on a Chip·Kristen L HeltonPaul Yager
May 5, 1999·Fundamental & Clinical Pharmacology·L BartheG Houin
Nov 16, 2013·International Journal of Nanomedicine·Anne-Claire GrooFrederic Lagarce
Jun 30, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Josias H HammanAwie F Kotzé
Jul 10, 2008·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Camile B WoitiskiFrancisco Veiga
Dec 3, 2014·Progress in Retinal and Eye Research·A J BronF V Bright
Apr 1, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Ana FortunaAmílcar Falcão
Oct 20, 2015·Expert Opinion on Drug Delivery·Gintare Leonaviciute, Andreas Bernkop-Schnürch
Jun 7, 2014·Journal of Pharmaceutical Sciences·Michael H Abraham
Aug 8, 2007·Journal of Pharmaceutical Sciences·Pranav ShahAmbikanandan Misra
May 5, 2004·Journal of Pharmaceutical Sciences·Zhiyong Gu, Paschalis Alexandridis
Nov 22, 2013·Journal of Pharmaceutical Sciences·Heike FriedlAndreas Bernkop-Schnürch
Dec 20, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Stephen T BuckleyMartin Brandl
Jan 4, 2012·Advanced Drug Delivery Reviews·Laura M EnsignJustin Hanes
Jun 29, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Dimple PablaHossein Zia
Nov 17, 2009·Otolaryngologic Clinics of North America·Richard J Harvey, Rodney J Schlosser
Jan 10, 2009·Advanced Drug Delivery Reviews·Samuel K LaiJustin Hanes
Jan 13, 2009·Advanced Drug Delivery Reviews·Yen Cu, W Mark Saltzman
Jan 13, 2009·Advanced Drug Delivery Reviews·Richard A Cone
May 4, 2007·International Journal of Pharmaceutics·Henry R CostantinoSteven C Quay
Feb 3, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Julia GrießingerAndreas Bernkop-Schnürch
Jan 16, 2016·Environmental Microbiology·Daniela Keilberg, Karen M Ottemann
Jan 25, 2005·International Journal of Pharmaceutics·Lance R ShawBarbara R Conway
Mar 24, 2009·IEEE Transactions on Nanobioscience·Shayna L McGillHugh D C Smyth
Jan 13, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·P L BardonnetF Falson
May 25, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kyoung-Jin LeeYong-Hee Lee
Oct 22, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·K GradauerR Prassl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.